50
Participants
Start Date
August 31, 2005
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Subcutaneous hydromorphone delivered by pain pen
Subcutaneous hydromorphone delivered by pain pen during breakthrough pain episodes, at max 4 daily. Dose established by opioid conversion from baseline opioids.
Dept. Neurology, Erasmus MC, Rotterdam
Lead Sponsor
Erasmus Medical Center
OTHER